Pfizer has asked Health Canada to approve the first COVID-19 vaccine for children aged five to 11 years old.The vaccine was developed in partnership with Germany’s BioNTech and is now marketed under the brand name Comirnaty.
It was authorized for people at least 16 years old last December, and for kids between 12 and 15 in May. ‘Parents are asking all the right questions,’ as COVID-19 vaccine for kids awaits approval: expert Pfizer already submitted clinical trial data for its child-sized dose to Health Canada at the beginning of the month.
The company said the results were comparable to those recorded in the Pfizer-BioNTech study in people aged 16 to 25.Health Canada said it will prioritize the review of the submission, while maintaining.